• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医药对2019冠状病毒病的潜在治疗作用:综述

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.

作者信息

Qiu Qin, Huang Yuge, Liu Xiaohua, Huang Fangfang, Li Xiaoling, Cui Liao, Luo Hui, Luo Lianxiang

机构信息

Graduate School, Guangdong Medical University, Zhanjiang, China.

Department of Pediatrics, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

出版信息

Front Pharmacol. 2020 Nov 9;11:570893. doi: 10.3389/fphar.2020.570893. eCollection 2020.

DOI:10.3389/fphar.2020.570893
PMID:33343347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7741169/
Abstract

The Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 has been rapidly spreading globally and has caused worldwide social and economic disruption. Currently, no specific antiviral drugs or clinically effective vaccines are available to prevent and treat COVID-19. Traditional Chinese medicine (TCM) can facilitate syndrome differentiation and treatment according to the clinical manifestations of patients and has demonstrated effectiveness in epidemic prevention and control. In China, TCM intervention has helped to control the epidemic; however, TCM has not been fully recognized worldwide. In this review, we summarize the epidemiology and etiological characteristics of severe acute respiratory syndrome coronavirus 2 and the prevention and treatment measures of COVID-19. Additionally, we describe the application of TCM in the treatment of COVID-19 and the identification of small molecules of TCM that demonstrate anti-coronavirus activity. We also analyze the current problems associated with the recognition of TCM. We hope that, through the contribution of TCM, combined with modern technological research and the support of our international counterparts, COVID-19 can be effectively controlled and treated.

摘要

由严重急性呼吸综合征冠状病毒2引起的2019年冠状病毒病(COVID-19)大流行已在全球迅速蔓延,并造成了全球社会和经济混乱。目前,尚无用于预防和治疗COVID-19的特定抗病毒药物或临床有效的疫苗。中医可以根据患者的临床表现进行辨证论治,并已在疫情防控中显示出有效性。在中国,中医干预有助于控制疫情;然而,中医尚未在全球得到充分认可。在本综述中,我们总结了严重急性呼吸综合征冠状病毒2的流行病学和病因特征以及COVID-19的预防和治疗措施。此外,我们描述了中医在治疗COVID-19中的应用以及具有抗冠状病毒活性的中药小分子的鉴定。我们还分析了当前与中医认知相关的问题。我们希望,通过中医的贡献,结合现代技术研究和国际同行的支持,COVID-19能够得到有效控制和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f4/7741169/0361de73a8ca/fphar-11-570893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f4/7741169/7b4233f949fe/fphar-11-570893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f4/7741169/0361de73a8ca/fphar-11-570893-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f4/7741169/7b4233f949fe/fphar-11-570893-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3f4/7741169/0361de73a8ca/fphar-11-570893-g002.jpg

相似文献

1
Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review.中医药对2019冠状病毒病的潜在治疗作用:综述
Front Pharmacol. 2020 Nov 9;11:570893. doi: 10.3389/fphar.2020.570893. eCollection 2020.
2
[Medication law and mechanism of traditional Chinese medicine in prevention and treatment of epidemic diseases: based on traditional Chinese medicine theory of cold pestilence].[中药防治疫病的用药规律及作用机制:基于中医寒疫理论]
Zhongguo Zhong Yao Za Zhi. 2022 Sep;47(17):4765-4777. doi: 10.19540/j.cnki.cjcmm.20220528.501.
3
[Research progress of intervention of Chinese herbal medicine and its active components on human coronavirus].[中草药及其活性成分干预人类冠状病毒的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1263-1271. doi: 10.19540/j.cnki.cjcmm.20200219.501.
4
[Rapid establishment of traditional Chinese medicine prevention and treatment of 2019-nCoV based on clinical experience and molecular docking].基于临床经验和分子对接快速建立中医药防治新型冠状病毒肺炎方案
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1213-1218. doi: 10.19540/j.cnki.cjcmm.20200206.501.
5
Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism.中医药治疗 COVID-19 相关器官损伤的治疗选择及作用机制。
Phytomedicine. 2021 May;85:153297. doi: 10.1016/j.phymed.2020.153297. Epub 2020 Aug 5.
6
Application of Traditional Chinese Medicine and Systems Pharmacology in Drug Prevention and Treatment against COVID-19.中药和系统药理学在新冠病毒防治药物中的应用。
Am J Chin Med. 2021;49(5):1045-1061. doi: 10.1142/S0192415X21500506.
7
Analysis of Traditional Chinese Medicine Diagnosis and Treatment Strategies for COVID-19 Based on "" from Chinese Authority.基于中国官方文献《新冠肺炎中医药诊疗方案》的分析。
Am J Chin Med. 2020;48(5):1035-1049. doi: 10.1142/S0192415X20500500.
8
Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.新冠肺炎恢复期继发肺纤维化患者采用中西医结合治疗的疗效:一项随机多中心试验。
Infect Dis Poverty. 2021 Mar 18;10(1):31. doi: 10.1186/s40249-021-00813-8.
9
Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.中药麻杏石甘-苇茎汤治疗新型冠状病毒肺炎重型急性呼吸综合征患者的疗效:一项随机对照试验研究方案的结构化总结
Trials. 2020 Dec 23;21(1):1029. doi: 10.1186/s13063-020-04970-3.
10
Advances in the treatment of novel coronavirus disease (COVID-19) with Western medicine and traditional Chinese medicine: a narrative review.新型冠状病毒肺炎(COVID-19)中西医治疗进展:一篇叙述性综述
J Thorac Dis. 2020 Oct;12(10):6054-6069. doi: 10.21037/jtd-20-1810.

引用本文的文献

1
A practical guide to implementing artificial intelligence in traditional East Asian medicine research.在传统东亚医学研究中实施人工智能的实用指南。
Integr Med Res. 2024 Sep;13(3):101067. doi: 10.1016/j.imr.2024.101067. Epub 2024 Jul 7.
2
An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine.基于中西医结合的中药预防新型冠状病毒肺炎的最新荟萃分析。
Front Pharmacol. 2023 Nov 13;14:1257345. doi: 10.3389/fphar.2023.1257345. eCollection 2023.
3
Therapeutic potential of traditional Chinese medicine on heat stroke.

本文引用的文献

1
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M) inhibitors to unveil a hope against COVID-19.多维计算机筛选策略鉴定天然多酚类化合物作为 SARS-CoV-2 主蛋白酶(Mpro)抑制剂,以期为抗击 COVID-19 带来新希望。
Comput Biol Med. 2022 Jun;145:105452. doi: 10.1016/j.compbiomed.2022.105452. Epub 2022 Mar 26.
2
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.连花清瘟胶囊治疗新型冠状病毒肺炎有效性和安全性的多中心前瞻性随机对照临床试验
Phytomedicine. 2021 May;85:153242. doi: 10.1016/j.phymed.2020.153242. Epub 2020 May 16.
3
中药对中暑的治疗潜力。
Front Pharmacol. 2023 Sep 25;14:1228943. doi: 10.3389/fphar.2023.1228943. eCollection 2023.
4
Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19.补充和替代医学在 COVID-19 辅助治疗中的疗效分析与研究进展。
J Biomed Sci. 2023 May 3;30(1):30. doi: 10.1186/s12929-023-00923-5.
5
The Potential of Vouacapanes from Vogel Against COVID-19 Cytokine Storm.来自沃格尔的沃阿卡潘类化合物对抗 COVID-19 细胞因子风暴的潜力。
Adv Pharm Bull. 2023 Jan;13(1):150-159. doi: 10.34172/apb.2023.016. Epub 2021 Oct 10.
6
Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101).用于新冠肺炎管理的中药方剂:特别参考台湾清冠一号(NRICM101)
Front Pharmacol. 2022 Oct 5;13:928106. doi: 10.3389/fphar.2022.928106. eCollection 2022.
7
Prevention and management of adverse events following COVID-19 vaccination using traditional Korean medicine: An online survey of public health doctors.运用韩医学预防和管理新型冠状病毒肺炎疫苗接种后的不良事件:一项针对公共卫生医生的在线调查
World J Clin Cases. 2022 Oct 6;10(28):10053-10065. doi: 10.12998/wjcc.v10.i28.10053.
8
Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine.参附注射液治疗老年重症肺炎的疗效与安全性:基于中西医结合的系统评价与Meta分析
Front Pharmacol. 2022 Aug 25;13:779942. doi: 10.3389/fphar.2022.779942. eCollection 2022.
9
Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action.中药抗病毒成分及其作用机制的研究进展。
Pharm Biol. 2022 Dec;60(1):1063-1076. doi: 10.1080/13880209.2022.2074053.
10
Editorial: Ethnopharmacological Responses to the Coronavirus Disease 2019 Pandemic.社论:对2019年冠状病毒病大流行的民族药理学反应
Front Pharmacol. 2021 Dec 3;12:798674. doi: 10.3389/fphar.2021.798674. eCollection 2021.
Master equation analysis of mesoscopic localization in contagion dynamics on higher-order networks.
高阶网络上传染动力学中微观定位的主方程分析
Phys Rev E. 2021 Mar;103(3-1):032301. doi: 10.1103/PhysRevE.103.032301.
4
A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19).利用 CT 图像进行冠状病毒病(COVID-19)筛查的深度学习算法。
Eur Radiol. 2021 Aug;31(8):6096-6104. doi: 10.1007/s00330-021-07715-1. Epub 2021 Feb 24.
5
Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China.中成药在中国治疗新型冠状病毒肺炎(COVID-19)中的应用
Front Pharmacol. 2020 Jul 17;11:1066. doi: 10.3389/fphar.2020.01066. eCollection 2020.
6
Similarities in Cutaneous Histopathological Patterns between COVID-19-positive and COVID-19 High-risk Patients with Skin Dermatosis.COVID-19 阳性患者与 COVID-19 高风险伴皮肤疾病患者的皮肤组织病理形态学表现存在相似性。
Acta Derm Venereol. 2020 Aug 19;100(15):adv00249. doi: 10.2340/00015555-3612.
7
Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients.金银花汤剂中被吸收的植物MIR2911可抑制新型冠状病毒复制并加速感染患者转阴。
Cell Discov. 2020 Aug 5;6(1):54. doi: 10.1038/s41421-020-00197-3. eCollection 2020.
8
[Analysis of medication regularity and pharmacodynamic characteristics of traditional Chinese medicine treatment in 444 severe cases of COVID-19].444例新冠肺炎重症病例中医治疗用药规律及药效学特征分析
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(13):3007-3012. doi: 10.19540/j.cnki.cjcmm.20200427.501.
9
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
10
The study on the treatment of Xuebijing injection (XBJ) in adults with severe or critical Corona Virus Disease 2019 and the inhibitory effect of XBJ against SARS-CoV-2.血必净注射液(XBJ)治疗成人新型冠状病毒肺炎重型及危重型的研究及XBJ对严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)的抑制作用
Pharmacol Res. 2020 Oct;160:105073. doi: 10.1016/j.phrs.2020.105073. Epub 2020 Jul 9.